Concepedia

Michel Maillard

MM

16

Publications

1K

Citations

14

H-Index

1989

Active since

Affiliations

CHDI Foundation(Current)

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Centre National de la Recherche Scientifique

Charles River Laboratories (United Kingdom)

Michel Maillard is an author at CHDI Foundation specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1989–2022

16

Publications

16

8‐(3‐Chlorostyryl)caffeine (CSC) is a selective A<sub>2</sub>‐adenosine antagonist in vitro and in vivo

Kenneth A. Jacobson, Olga Nikodijević, William L. Padgett et al. · FEBS Letters · 1993 · 172 citations · Full text

Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists

Kenneth A. Jacobson, Carola Gallo‐Rodriguez, Neli Melman et al. · Journal of Medicinal Chemistry · 1993 · 148 citations · Full text

Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease

Roland W. Bürli, Christopher A. Luckhurst, Omar Aziz et al. · Journal of Medicinal Chemistry · 2013 · 147 citations · Full text

, , +19

Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase

Michel Maillard, Roy K. Hom, Timothy E. Benson et al. · Journal of Medicinal Chemistry · 2007 · 110 citations · Full text

Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P<sub>2</sub> purinoceptors: Heterogeneity within P<sub>2x</sub> and P<sub>2y</sub> subtypes

Geoffrey Burnstock, Bilha Fischer, Charles H.V. Hoyle et al. · Drug Development Research · 1994 · 99 citations · Full text

Rows per page

1–5 of 16